Skip to content

MDMA research published in 2018

Page 5 of 5: studies 81 to 82 of 82, newest first. Back to the MDMA overview

Studies

The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)

Drug Science, Policy and Law 2018 Torsten Passie 115 citations

3,4-Methylenedioxymethamphetamine (MDMA), also known as ecstasy, was first synthesized in 1912 but first reached widespread popularity as a legal alternative after the much sought-after recreational drug 3,4-methylenedioxy-amphetamine (MDA) was made illegal in 1970. Because of its benign, feeling-enhancing, and nonhallucinatory properties, MDMA was used by a few dozen psychotherapists in the...

Pharmacies as potential providers of harm reduction services: A preliminary online survey

Drug Science, Policy and Law 2018 Edward James, Thomas L Robertshaw, Andrew D. Westwell et al. 4 citations

Background Recreational drug use is a major cause of disease, injury, physical and mental impairment and death in developed countries such as the United Kingdom and the United States. Alcohol, tobacco, cannabis, 3,4-methylenedioxymethamphetamine (MDMA) and psilocybe mushrooms are recreational drugs with capacity to cause harm. Cannabis, MDMA and psilocybin have reported therapeutic...